STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company through a distribution of its shares to existing shareholders of ContextVision. The company will build […]

On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm. The Board’s proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital Pathology to the shareholders of ContextVision AB, was approved. No other matters were processed at […]

The shareholders of ContextVision AB, corporate registration number 556377-8900, are hereby invited to attend an extraordinary general meeting on the 10 December, 2021 at 10 a.m CET at ContextVision AB’s office, Klara Norra Kyrkogata 31, 111 22, Stockholm. Right to participate and notification Shareholders who wish to participate in the annual general meeting with the […]

Martin Ingvar, Member of the Board of ContextVision, has on October 21, 2021 purchased 6,000 shares in ContextVision AB at an average price of NOK 22.10 per share. After the transaction, Mr Ingvar holds a total of 12,000 shares in ContextVision AB.

Martin Ingvar, Member of the Board of ContextVision, has on September 1, 2021 purchased 6,000 shares in ContextVision AB at an average price of NOK 24.41 per share. After the transaction, Mr Ingvar holds a total of 6,000 shares in ContextVision AB.